Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
The pharmaceutical market for targeted therapies continues to expand, driving significant demand for critical intermediates. Vemurafenib (CAS 1029872-54-5), a vital component in the treatment of specific cancers, is a key player in this dynamic sector. Understanding the market trends and supplier landscape for this compound is crucial for pharmaceutical manufacturers aiming to secure a reliable and cost-effective supply chain.
Vemurafenib, with its chemical designation N-[3-[[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]-2,4-difluorophenyl]-1-propanesulfonamide, is a high-value pharmaceutical intermediate. Its application in treating conditions like BRAF V600E-mutated melanoma has established its importance. As a result, the market for Vemurafenib is directly linked to the prevalence of these mutations and the adoption rates of targeted therapies.
Key factors influencing the Vemurafenib price include production costs, regulatory compliance, and global supply and demand. Pharmaceutical buyers often seek to purchase Vemurafenib CAS 1029872-54-5 in bulk to leverage economies of scale. Negotiating competitive pricing from manufacturers, particularly those in regions like China, is a common strategy to manage drug production expenses. However, price should not be the sole determinant; quality and reliability are paramount.
When evaluating potential suppliers for Vemurafenib, several aspects are critical. A reputable manufacturer will provide detailed Certificates of Analysis (CoAs) confirming the compound's identity, purity (typically >98%), and physical properties, such as its off-white solid appearance and solubility in DMSO and methanol. Furthermore, a dependable supplier will have established quality management systems, potentially including GMP certifications, and robust logistics to ensure timely delivery worldwide.
The global landscape for pharmaceutical intermediates is competitive. Buyers often compare multiple manufacturers and suppliers before making a purchase decision. Understanding the market dynamics, including potential supply chain disruptions and evolving regulatory requirements, allows procurement professionals to make informed choices. For those looking to buy Vemurafenib, diligent research into potential suppliers, their production capabilities, and their track record is an investment in the success of their pharmaceutical products.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
